EORTC

Highlights from an EU Medicines Agency-EORTC workshop – The Lancet Oncology

The Lancet Oncology shared a post on X:

“Online first: highlights from an EU Medicines Agency – EORTC workshop: using patient-reported outcomes and QoL data in regulatory decisions:

Perspective:

‘Using patient-reported outcomes and health-related quality of life data in regulatory decisions on cancer treatment: highlights from an EMA-EORTC workshop’

Authors: Madeline Pe et al.

Highlights from an EU Medicines Agency-EORTC workshop - The Lancet Oncology

Comment:

‘Use of patient-reported outcomes to inform symptom and functional outcomes in cancer drug regulatory decisions: challenges and future directions’

Authors: Francesco Pignatti et al.”

Highlights from an EU Medicines Agency-EORTC workshop - The Lancet Oncology

More posts featuring The Lancet Oncology.

cancer EMA EORTC EU Medicines Agency Francesco Pignatti Madeline Pe OncoDaily Oncology The Lancet Oncology